Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US

Recruiting Observational Study
Hypertension Dyslipidemias Type 2 Diabetes HIV-1-infection
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
150 (estimated)
Sponsor
Duke University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study has 3 aims. Aim 1: Identify social determinants of cardiometabolic health and determine facilitators and modifiable barriers in achieving treatment goals. Aim 2: Assess PLWH knowledge, skills, and confidence for self-management of cardiometabolic disorders. Aim 3: Tailor a self-management support and education intervention with stakeholder input to address barriers to achieving treatm…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Aims 1 and 2 * People living with HIV who are at least 35 years of age and who have one or more of the following conditions: hypertension, dyslipidemia, or type 2 diabetes. Aim 3 * Participants recruited from the participating clinics and community based organizations and may…
Contacts

Stuart T Carr, BA

919 668-4849

stuart.carr@duke.edu

CONTACT

Charles Muiruri, PhD

919 660-3212

charles.muiruri@duke.edu

CONTACT